How can we use our growing understanding of gene transcription to discover effective new medicines?
- 1 December 1997
- journal article
- review article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 8 (6) , 713-717
- https://doi.org/10.1016/s0958-1669(97)80125-5
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Cyclosporin A, an Immunosuppressive Drug, Induces Programmed Cell Death in Rat C6 Glioma Cells by a Mechanism that Involves the AP-1 Transcription FactorJournal of Neurochemistry, 2002
- Solution structure of the calicheamicin γ1I-DNA complexJournal of Molecular Biology, 1997
- Solution structure of the esperamicin A1-DNA complexJournal of Molecular Biology, 1997
- Positive selection system to screen for inhibitors of human immunodeficiency virus-1 transcriptionNature Biotechnology, 1996
- A new immunosuppressant: tacrolimusPublished by Oxford University Press (OUP) ,1996
- Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4Nature, 1996
- Peptide mimetic drugs: A comment on progress and prospectsNature Biotechnology, 1996
- Distamycin A Complexation with a Nucleic Acid Triple HelixBiochemistry, 1996
- Nonpeptidal P2 Ligands for HIV Protease Inhibitors: Structure-Based Design, Synthesis, and Biological EvaluationJournal of Medicinal Chemistry, 1996
- Interference with the assembly of a virus-host transcription complex by peptide competitionNature, 1990